The Mainz-based company BioNTech that shot to global notoriety amid the COVID-19 pandemic for its work on one of the first mRNA coronavirus vaccines has announced drastic restructuring plans.  The company is winding down its COVID vaccine production entirely, leaving the production to US partner  Pfizer going forward. "In the course of this year we will produce the last doses here in Germany," a company spokeswoman told the Reuters news agency.  Amid the restructuring, the company is closing

Tag-uri: Pfizer Coronavirus